pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,475 catalysts · 5,159 phase readout · 2,342 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 47 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout5,159
  • 8k filing2,342
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04514029: Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

    Sponsor: Masonic Cancer Center, University of Minnesota. Phase: EARLY_PHASE1. Conditions: Lymphoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07114731: Comparison of Synchronous and Asynchronous Action Observation Therapy in Children With Cerebral Palsy

    Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Cerebral Palsy (CP), Spastic Diplegia Cerebral Palsy, Spastic Hemiplegic Cerebral Palsy, Neurodevelopmental Disorder (Diagnosis), Action Observation, Action Observation Therapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02156102: Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Genetic Disease, Genomics

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03553602: HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer

    Sponsor: Loyola University. Phase: PHASE1. Conditions: Prostate Cancer - Recurrent

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05846737: BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07601737: Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

    Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07569445: Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome

    Sponsor: University of Rochester. Phase: . Conditions: Rett Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07417072: GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients

    Sponsor: Meyer Children's Hospital IRCCS. Phase: NA. Conditions: Pediatric Brain Tumors, Genomics, Epigenetic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07419672: Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste

    Sponsor: Church & Dwight Company, Inc.. Phase: NA. Conditions: Dental Caries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07559695: A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT

    Sponsor: The First Affiliated Hospital of Soochow University. Phase: . Conditions: Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy, KMT2A Rearrangement, NPM1 Mutation, NUP98 Gene Rearrangement

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05675995: Qigong for Post Acute Sequelae of COVID-19 Infection

    Sponsor: University of California, Davis. Phase: NA. Conditions: Long COVID

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04453475: Feasibility and Benefits of Digital Services During the COVID19 Pandemic

    Sponsor: Jacobs University Bremen gGmbH. Phase: NA. Conditions: Psychosomatic Disorder, Psychological Distress, Psychological Stress, Psychological Disease, Psychological Disorder, Psychological Impairment, Psychological Disability, Psychological Adjustment, Psychological Adaptation, Communication, Health Care Seeking Behavior, Anxiety, Behavior, Health, Health Risk Behaviors, Healthy Lifestyle

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07379775: Evaluation of the Reliability of AAR as an Independent Tool for Surgical Indication in Nasal Obstruction

    Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: . Conditions: Nasal Obstruction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06930001: Etamine Processing on Episiotomy Repair Skills, Stress and Learning Attitudes in Midwifery Students

    Sponsor: Selcuk University. Phase: NA. Conditions: Episiotomy Repair Skills, Learning Attitude

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03695601: Surveillance HeartCare® Outcomes Registry

    Sponsor: CareDx. Phase: . Conditions: Heart Transplant Rejection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07342881: Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

    Sponsor: Aligos Therapeutics. Phase: PHASE1. Conditions: Chronic Hepatitis B Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07462312: MentalGym™ and NeuroBrave™ Guided Wearable-Assisted Physiology Regulation Training for PTSD (PRTP)

    Sponsor: NeuroBrave ltd.. Phase: NA. Conditions: PTSD - Post Traumatic Stress Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02224781: Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Recurrent Melanoma, Unresectable Melanoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07623330: Use of TEE Derived Measurement vs Direct Measurement Under General Anesthesia in Assessment of Pressure Gradient in Peri Membranous Ventricular Septal Defect

    Sponsor: Ain Shams University. Phase: . Conditions: Peri Membranous Ventricular Septal Defect

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07254728: A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

    Sponsor: Vaxart. Phase: PHASE1. Conditions: Norovirus Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07448467: Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema.

    Sponsor: Uskudar University. Phase: NA. Conditions: Lymphedema, Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07575100: Maitland Mobilization Versus Therapeutic Ultrasound on Trismus Following Third Molar Surgery

    Sponsor: Cairo University. Phase: NA. Conditions: Postoperative Trismus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05847192: Tau Networks in Psychotic Alzheimer's Disease

    Sponsor: Northwell Health. Phase: . Conditions: Alzheimer Disease, Alzheimer Disease With Delusions, Alzheimer Disease With Psychosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07232992: Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Open-Heart Surgery

    Sponsor: Bursa City Hospital. Phase: NA. Conditions: Serratus Posterior Superior Intercostal Plane Block (SPSIPB), Open-heart Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04554992: Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

    Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Covid19

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT02130492: A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Advanced Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07325136: A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Relapsed/Refractory Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04259892: Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Coronavirus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05907811: General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia

    Sponsor: Yuzuncu Yil University. Phase: NA. Conditions: Thoracic Epidural Analgesia, Gastric Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07304271: Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis

    Sponsor: Magnus Nilsson. Phase: PHASE3. Conditions: Gastric Cancer Peritoneal Metastases

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07424144: An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps

    Sponsor: Sanofi. Phase: PHASE3. Conditions: Chronic Rhinosinusitis With Nasal Polyps

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07226609: A Dietary Study for People With Multiple Myeloma

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07294664: PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

    Sponsor: The First Affiliated Hospital of Zhengzhou University. Phase: PHASE2. Conditions: Advanced Gastric Cancer, SHR1701

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04363164: Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Castration Resistant Metastatic Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05680363: Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

    Sponsor: Fecundis S.A.. Phase: NA. Conditions: Infertility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07184463: A Study of Pain Reduction After Pulmonary Resection by RATS-TT, RATS-OTC, and Hybrid RATS.

    Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: . Conditions: Thoracic Surgery, Video-assisted Thoracic Surgery, Robotic-assisted Thoracic Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06052163: Bumetanide in Patients With Alzheimer's Disease

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Alzheimer Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07283263: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05870787: iMproving thE DIagnostics And Treatment Of ceRvical Precancer

    Sponsor: University of Aarhus. Phase: . Conditions: Cervical Dysplasia, Cervical Disease, Cervical Lesion, Cervical Cancer, Cervical Neoplasm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05831787: COVID19 OutcomeS in Myeloma and the Impact of VaCcines

    Sponsor: ASH Research Collaborative. Phase: . Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04136353: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

    Sponsor: University of Sydney. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06982131: A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

    Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Overweight, Obesity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07387237: Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal

    Sponsor: Unidade Local De Saúde Do Norte Alentejano. Phase: . Conditions: Gastric Cancer (Diagnosis), Stomach Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06100237: Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

    Sponsor: Carl Ola Landgren, MD, PhD. Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06560645: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

    Sponsor: Prelude Therapeutics. Phase: PHASE1. Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Carcinoma, SMARCA4 Mutation, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction Squamous Cell Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06011733: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

    Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06151847: Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

    Sponsor: University of Kansas Medical Center. Phase: PHASE2. Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Unresectable Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03986047: Effect of Thermal Therapy and Exercises on Acute Low Back Pain

    Sponsor: Laval University. Phase: NA. Conditions: Low Back Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07548658: Mind Mapping: Impact on Critical Thinking and Problem-Solving Skills

    Sponsor: Gazi University. Phase: NA. Conditions: Mind Mapping, Nursing Students, Critical Thinking

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07543458: Therapeutics for Moderate and Severe Dengue

    Sponsor: Oxford University Clinical Research Unit, Vietnam. Phase: PHASE3. Conditions: Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA Virus Infections, Hemorrhagic Fever

    full page →ctgov ↗
    ← prev
    page 102 of 110
    next →